Announcement
01 Jul 2020
In July 2020, the Norwegian authorities introduced an export ban on rivaroxaban following the outbreak of COVID-19.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
01 Jul 2020
Revocation date:
13 Jul 2020
On 1 July 2020, the Norwegian Medicines Agency introduced an export ban on rivaroxaban. The export ban was introduced due to concerns of shortages following the outbreak of COVID-19. The good was p...
See all
This state act is not part of any Thread yet.